Skip to main content
Clinical Trials/JPRN-jRCTs062200061
JPRN-jRCTs062200061
Recruiting
Phase 2

Exploratory clinical study on the prevention effect of Docetaxel-induced peripheral neuropathy by compression therapy using surgical gloves and lower limb stockings - Glove stocking study for Decetaxel -induced peripheral neuropathy

Kato Takuma0 sites75 target enrollmentMarch 11, 2021

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
prostate cancer
Sponsor
Kato Takuma
Enrollment
75
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 11, 2021
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Male

Investigators

Sponsor
Kato Takuma

Eligibility Criteria

Inclusion Criteria

  • 1\) Prostate cancer patients to whom docetaxel / prednin therapy is introduced
  • 2\) Patients who are over 20 years old and have given their written consent
  • 3\) Hand size patients within the size range of commercially available surgical gloves.
  • 4\) Protect X Intense pressure support (ML size; height less than 178cm, calf circumference less than 44cm, thigh circumference less than 52cm, foot size 25 to 28cm), Protect X Intense pressure support (L\-LL size; height more than 175cm calf Patients who can wear around 42cm to 52cm around the thigh, around 50 to 62cm around the thigh and 27 to 30cm of foot size)

Exclusion Criteria

  • 1\) Patients with peripheral neuropathy at the start of the study
  • 2\) Patients who have received medications that may cause peripheral neuropathy in the past.
  • 3\) Patients with extremely small or large hands that fall outside the size range of commercially available surgical gloves.
  • 4\) Patients with extreme finger and leg deformities
  • 5\) Patients with acute deep vein thrombosis
  • 6\) Patients with thrombophlebitis of the superficial vein of lower limb
  • 7\) Patients with arterial circulation disorders such as obstructive arteriosclerosis, congestive heart failure, inflammatory or purulent diseases of lower limbs, and acute wounds
  • 8\) Patients with necrosis / gangrene, severe edema, purulent skin disease after skin transplantation
  • 9\) Diabetic patients with peripheral neuropathy
  • 10\) Patient whose ankle circumference exceeds 27cm

Outcomes

Primary Outcomes

Not specified

Similar Trials